We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Discontinued Formulation of Protonix IV Is Unsafe for Generics, FDA Says
Discontinued Formulation of Protonix IV Is Unsafe for Generics, FDA Says
The FDA will not approve generics referring to the original and discontinued formulation of Protonix IV, after a review of scientific data confirmed that therapy for gastroesophageal reflux disease was pulled off the market for safety reasons.
